A Senate vote to halt a Medicare pilot that uses artificial intelligence to approve or deny care failed along party lines on ...
MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Turmoil at the American ...
ATLANTA — Federal health officials have identified lettuce from Mexico served at Taco Bell locations across five U.S. states as a source of a widespread outbreak of diarrhea-causing parasite ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular ...
Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...
A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...
Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results